Impact Factor
3.31
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
2.44
231 total citations
h5-index
37
h5 depth signal
Cited share
76.5%
75 of 98
Total citations
231
Citation footprint
Metric signal
3.06
External metric anchor
Self-citation
2.6%
6 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
503
United Kingdom
144
Germany
135
Australia
127
Canada
93
Citing Fields of Research
Diabetes
1,095
Nutrition & Dietetics
92
Endocrinology & Metabolism
66
Genetics & Genomics
45
Psychiatry
34
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
2,645
Articles tracked across the journal lifetime
Indexed publication set
98
75 cited publications
Last 12 months
26
26.0 publications/month
Open access share
96.2%
25 OA publications in the last year
Leading citing country
United States
503 citing publications
Leading citing field
Diabetes
1,095 citing publications
Latest tracked publication
20 January 2026
10 recent records available
Coverage & Indexing History
v4n1, Mar. 2003-
v4n1, Mar. 2003-
Active Coverage
Active Coverage
Research Focus & Classification
Indexed Subjects
Diabetes
Broad Categories
Endocrinology
Diabetes
MeSH Descriptors
Child
Diabetes Mellitus
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1155/pedi/3418021
Open DOI
Maternal Autoimmune Disease and Childhood‐Onset Type 1 Diabetes: A Nationwide Population‐Based Nested Case‐Control Study
Introduction: Type 1 diabetes mellitus (T1DM) is an autoimmune disease that damages insulin‐producing pancreatic cells, often appearing in childhood. Global incidence is rising at 2%–3% yearly. Its exact cause is unclear. Prenatal exposu...
02
DOI 10.1155/pedi/5539725
Open DOI
From Pathophysiology to Treatment: Contemporary Approaches to CFRD in the Pediatric and Adolescent Population
Cystic fibrosis‐related diabetes (CFRD) is the most prevalent nonrespiratory complication of cystic fibrosis (CF), with its prominence growing as survival rates improve due to advances in CFTR modulator therapies. Its prevalence increase...
03
04
DOI 10.48130/pedi-0026-0011
Open DOI
A randomized trial of a structured experiential intervention to reduce parenting stress in parents of children with type 1 diabetes BEM 02-study
Parents of children with type 1 diabetes experience substantial stress, anxiety, and sleep difficulties. We evaluated the effectiveness of Body Emotional Maps (BEM), an experiential group intervention delivered during a diabetes camp, co...
05
DOI 10.48130/pedi-0026-0008
Open DOI
Open-source automated insulin delivery shows comparable glycemic outcomes to a commercial hybrid closed-loop system in real-world type 1 pediatric diabetes care: a retrospective cohort study from British Columbia, Canada
Open-source automated insulin delivery shows promise for managing type 1 diabetes, though pediatric efficacy and safety data remain limited. This study aimed to compare real-world glycemic outcomes of open-source automated insulin delive...
06
DOI 10.48130/pedi-0026-0009
Open DOI
Bihormonal fully closed-loop glucose control in adolescents with Type 1 diabetes: an outpatient, randomized, crossover trial
Effective diabetes management in adolescents with Type 1 diabetes is crucial to reduce the risk of long-term complications. However, adolescents show the poorest glycemic outcomes of all age groups. A bihormonal fully closed-loop (FCL) s...
07
DOI 10.48130/pedi-0026-0007
Open DOI
A randomized trial comparing supplemental video care and asynchronous remote monitoring among young people with type 1 diabetes and elevated glycemic levels
Telehealth can enable supplemental care to young people with type 1 diabetes (T1D) in need of frequent guidance or treatment changes. However, the relative benefits of different telehealth modalities (e.g., synchronous video visits versu...
08
DOI 10.48130/pedi-0026-0006
Open DOI
Efficacy and safety of hybrid closed-loop systems in children aged < 7 years with type 1 diabetes: a systematic review and meta-analysis of randomized controlled trials
This study aimed to evaluate the clinical efficacy and safety of hybrid closed-loop systems for glycemic control in children aged < 7 years with Type 1 diabetes. Relevant studies published up to July 30, 2025 were electronically retrieve...
09
DOI 10.48130/pedi-0026-0005
Open DOI
Celiac disease and celiac serology in children with Type 1 Diabetes: diagnostic timing, serologic patterns, and implications for long-term management
The prevalence of celiac disease (CeD) in children with type 1 diabetes mellitus (T1DM) is significant, and celiac serology screening is routinely done in T1DM patients. The sequence of CeD and T1DM diagnosis and the natural history of t...
10
DOI 10.48130/pedi-0026-0001
Open DOI
Barriers and facilitators to the implementation of school-partnered collaborative type 1 diabetes interventions: a qualitative comparative analysis with school nurses to guide implementation
Though school-partnered interventions have the potential to improve health outcomes, data are limited to support their implementation for type 1 diabetes. The objective was to characterize barriers and facilitators (i.e., determinants) t...
Bibliographical & Catalog Notes
Title from cover.
Print issues ceased with v. 15, no. 8 (Dec. 2014).
Also issued online.